Granules Pharma Completes US FDA Post-Marketing Adverse Drug Experience Inspection with Zero Observations

Granules India Limited, a vertically integrated and rapidly growing Indian pharmaceutical company, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company based in Chantilly, Virginia, USA,....

Zydus Lifesciences Gets USFDA Approval for Generic Rheumatoid Arthritis Treatment Drug

Later this week, Zydus Lifesciences Ltd announced that it has gained final permission from the US Food and Drug Administration to manufacture and market its generic Indomethacin suppositories for moderate to severe rheumatoid arthritis...

Yashoda Medicity, Indirapuram and Draeger India Partners to Establish South Asia's largest Modular ICU Setup

Yashoda Medicity, an upcoming healthcare facility in Indirapuram by Yashoda Foundations, is collaborating with Draeger India, a renowned global provider of medical and safety technology solutions...

Pharma Firms with more than Rs 250 crores Turnover to be Given 6 months to Adopt Good Manufacturing Practices says Official Sources

According to official sources, pharma companies with a turnover of more than Rs 250 crore will have six months to implement Good Manufacturing Practises, while companies with a turnover of less than Rs 250 crore will have twelve months...

Flawless Pharma to Invest USD 100 Million in Buyout of Assets & Patents in Hong Kong and China

Flawless Pharma Private Limited, a research-based integrated pharmaceutical company involved in niche API manufacturing and marketing of pharmaceutical ingredient supplier for leading formulators with services such as APIs, custom pharmaceutical...

Glenmark Pharma, OMRON Healthcare India Partners To Combat Hypertension Ignorance Among Young Adults in India

Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led global pharmaceutical company, has partnered with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring...

Amarin, Lotus Pharma Collaborates to Commercialize Vazkepa in Southeast Asia and South Korea

Amarin Corporation plc, an innovative pharmaceutical company, and Lotus Pharmaceuticals, a global pharmaceutical company, announced a long-term exclusive partnership to distribute and commercialise Vazkepa (icosapent ethyl) in ten countries,...

Indian Pharma Firms Looking Forward to Export Medicines to Fiji as per PIC/S Standard

Indian pharma companies are looking forward to export medicines to Fiji based on a government tender for medicine supply as per the Pharmaceutical Inspection Co-operation Scheme (PIC/S) standard...

Glenmark Receives USFDA approval to Market Generic Diabetes Drug

Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market a generic diabetes drug in the American market...

Gujarat-based Pharma firm Develops Potential Treatment for Diabetic Neuropathy

Asprius Lifesciences, a pharmaceutical company based in Gujarat, has developed a new treatment for diabetic neuropathy, a condition that causes nerve damage in the body's peripheral areas....

© 2025 India Pharma Outlook. All Rights Reserved.